183 related articles for article (PubMed ID: 23418396)
21. Native somatostatin sst2 and sst5 receptors functionally coupled to Gi/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophs.
Cervia D; Fehlmann D; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):578-87. PubMed ID: 12750875
[TBL] [Abstract][Full Text] [Related]
22. Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures.
Mohamed A; Blanchard MP; Albertelli M; Barbieri F; Brue T; Niccoli P; Delpero JR; Monges G; Garcia S; Ferone D; Florio T; Enjalbert A; Moutardier V; Schonbrunn A; Gerard C; Barlier A; Saveanu A
Endocr Relat Cancer; 2014 Oct; 21(5):691-704. PubMed ID: 25012983
[TBL] [Abstract][Full Text] [Related]
23. Differential regulation of somatostatin receptor dephosphorylation by β-arrestin1 and β-arrestin2.
Kliewer A; Schulz S
Naunyn Schmiedebergs Arch Pharmacol; 2014 Mar; 387(3):263-9. PubMed ID: 24276218
[TBL] [Abstract][Full Text] [Related]
24. Drug design at peptide receptors: somatostatin receptor ligands.
Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D
J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345
[TBL] [Abstract][Full Text] [Related]
25. Site specificity of agonist and second messenger-activated kinases for somatostatin receptor subtype 2A (Sst2A) phosphorylation.
Liu Q; Bee MS; Schonbrunn A
Mol Pharmacol; 2009 Jul; 76(1):68-80. PubMed ID: 19389921
[TBL] [Abstract][Full Text] [Related]
26. Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization.
Durán-Prado M; Bucharles C; Gonzalez BJ; Vázquez-Martínez R; Martínez-Fuentes AJ; García-Navarro S; Rhodes SJ; Vaudry H; Malagón MM; Castaño JP
Endocrinology; 2007 Jan; 148(1):411-21. PubMed ID: 17053026
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin receptor expression and patients' response to targeted medical treatment in pituitary tumors: evidences and controversies.
Gatto F; Arvigo M; Ferone D
J Endocrinol Invest; 2020 Nov; 43(11):1543-1553. PubMed ID: 32557353
[TBL] [Abstract][Full Text] [Related]
28. Receptor signaling and endocytosis are differentially regulated by somatostatin analogs.
Liu Q; Cescato R; Dewi DA; Rivier J; Reubi JC; Schonbrunn A
Mol Pharmacol; 2005 Jul; 68(1):90-101. PubMed ID: 15855408
[TBL] [Abstract][Full Text] [Related]
29. Regulation of neuronal nitric-oxide synthase activity by somatostatin analogs following SST5 somatostatin receptor activation.
Cordelier P; Estève JP; Najib S; Moroder L; Vaysse N; Pradayrol L; Susini C; Buscail L
J Biol Chem; 2006 Jul; 281(28):19156-71. PubMed ID: 16690617
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of somatostatin and angiopeptin on cell proliferation.
Alderton F; Lauder H; Feniuk W; Fan TP; Humphrey PP
Br J Pharmacol; 1998 May; 124(2):323-30. PubMed ID: 9641549
[TBL] [Abstract][Full Text] [Related]
31. Somatostatin receptor type 5 modulates somatostatin receptor type 2 regulation of adrenocorticotropin secretion.
Ben-Shlomo A; Wawrowsky KA; Proekt I; Wolkenfeld NM; Ren SG; Taylor J; Culler MD; Melmed S
J Biol Chem; 2005 Jun; 280(25):24011-21. PubMed ID: 15857828
[TBL] [Abstract][Full Text] [Related]
32. Homologous and heterologous in vitro regulation of pig pituitary somatostatin receptor subtypes, sst1, sst2 and sst5 mRNA.
Luque RM; Park S; Peng XD; Delgado E; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
J Mol Endocrinol; 2004 Apr; 32(2):437-48. PubMed ID: 15072550
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies.
Siehler S; Seuwen K; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):488-99. PubMed ID: 10598788
[TBL] [Abstract][Full Text] [Related]
34. Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways.
Cescato R; Loesch KA; Waser B; Mäcke HR; Rivier JE; Reubi JC; Schonbrunn A
Mol Endocrinol; 2010 Jan; 24(1):240-9. PubMed ID: 19910453
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas.
Saveanu A; Gunz G; Guillen S; Dufour H; Culler MD; Jaquet P
Neuroendocrinology; 2006; 83(3-4):258-63. PubMed ID: 17047391
[TBL] [Abstract][Full Text] [Related]
36. Distinct phosphorylation sites in the SST2A somatostatin receptor control internalization, desensitization, and arrestin binding.
Liu Q; Dewi DA; Liu W; Bee MS; Schonbrunn A
Mol Pharmacol; 2008 Feb; 73(2):292-304. PubMed ID: 17981995
[TBL] [Abstract][Full Text] [Related]
37. Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.
Doll C; Pöll F; Peuker K; Loktev A; Glück L; Schulz S
Br J Pharmacol; 2012 Nov; 167(6):1259-70. PubMed ID: 22725608
[TBL] [Abstract][Full Text] [Related]
38. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation.
Spary EJ; Maqbool A; Batten TF
J Chem Neuroanat; 2008 Jan; 35(1):49-66. PubMed ID: 17646081
[TBL] [Abstract][Full Text] [Related]
39. A new
Mansi R; Abid K; Nicolas GP; Del Pozzo L; Grouzmann E; Fani M
EJNMMI Res; 2020 Aug; 10(1):90. PubMed ID: 32757150
[TBL] [Abstract][Full Text] [Related]
40. Activated G protein-coupled receptor induces tyrosine phosphorylation of STAT3 and agonist-selective serine phosphorylation via sustained stimulation of mitogen-activated protein kinase. Resultant effects on cell proliferation.
Sellers LA; Feniuk W; Humphrey PP; Lauder H
J Biol Chem; 1999 Jun; 274(23):16423-30. PubMed ID: 10347203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
